Semaglutide
- FDA Approved
- ✓Yes
- Prescription
- ✓Yes
- Strong Evidence
- ✓Yes
- Primary Goal
- Weight Management
- Administration
- Injection or oral; product-specific
- Score
- 9.1
MYPEPTIDEQUEST
Compare Peptide Treatments
Compare reviewed treatments using consistent evidence, regulatory, safety, administration, and access criteria.
Compare Peptide Treatments
Quickly compare approved treatments and research compounds by regulatory status, evidence, use, and access.
| Treatment | FDA Approved | Prescription | Strong Human Evidence | Weight Management | Metabolic Health | Bone Health | Recovery Research | Clinician Supervision | Administration | Score | Read Review |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-APPROVED / ESTABLISHED | |||||||||||
| Semaglutide | ✓Yes | ✓Yes | ✓Yes | ✓Yes | ✓Yes | ✓Yes | Injection or oral; product-specific | 9.1 | Read Review | ||
| Tirzepatide | ✓Yes | ✓Yes | ✓Yes | ✓Yes | ✓Yes | ✓Yes | Weekly injection | 9.1 | Read Review | ||
| Liraglutide | ✓Yes | ✓Yes | ✓Yes | ✓Yes | ✓Yes | ✓Yes | Daily injection | 8.7 | Read Review | ||
| Teriparatide | ✓Yes | ✓Yes | ✓Yes | ✓Yes | ✓Yes | Daily injection | 8.6 | Read Review | |||
| Abaloparatide | ✓Yes | ✓Yes | ✓Yes | ✓Yes | ✓Yes | Daily injection | 8.3 | Read Review | |||
| Glucagon | ✓Yes | ✓Yes | ✓Yes | ✓Yes | ✓Yes | Nasal or injection; product-specific | 9.1 | Read Review | |||
| RESEARCH / UNAPPROVED | |||||||||||
| BPC-157Research Use | ✕No | ✕No | ✕No | ✓Yes | No approved route | Read Evidence | |||||
| TB-500Research Use | ✕No | ✕No | ✕No | ✓Yes | No approved route | Read Evidence | |||||
| MOTS-CResearch Use | ✕No | ✕No | ✕No | ✓Yes | No approved route | Read Evidence | |||||
| CJC-1295Research Use | ✕No | ✕No | ✕No | No approved route | Read Evidence | ||||||
| IpamorelinResearch Use | ✕No | ✕No | ✕No | No approved route | Read Evidence | ||||||
FDA-APPROVED / ESTABLISHED
Tirzepatide
- FDA Approved
- ✓Yes
- Prescription
- ✓Yes
- Strong Evidence
- ✓Yes
- Primary Goal
- Weight Management
- Administration
- Weekly injection
- Score
- 9.1
Liraglutide
- FDA Approved
- ✓Yes
- Prescription
- ✓Yes
- Strong Evidence
- ✓Yes
- Primary Goal
- Weight Management
- Administration
- Daily injection
- Score
- 8.7
Teriparatide
- FDA Approved
- ✓Yes
- Prescription
- ✓Yes
- Strong Evidence
- ✓Yes
- Primary Goal
- Bone Health
- Administration
- Daily injection
- Score
- 8.6
Abaloparatide
- FDA Approved
- ✓Yes
- Prescription
- ✓Yes
- Strong Evidence
- ✓Yes
- Primary Goal
- Bone Health
- Administration
- Daily injection
- Score
- 8.3
Glucagon
- FDA Approved
- ✓Yes
- Prescription
- ✓Yes
- Strong Evidence
- ✓Yes
- Administration
- Nasal or injection; product-specific
- Score
- 9.1
RESEARCH / UNAPPROVED
BPC-157
- FDA Approved
- ✕No
- Prescription
- ✕No
- Strong Evidence
- ✕No
- Recovery Research
- ✓Yes
- Administration
- No approved route
- Score
- —
TB-500
- FDA Approved
- ✕No
- Prescription
- ✕No
- Strong Evidence
- ✕No
- Recovery Research
- ✓Yes
- Administration
- No approved route
- Score
- —
MOTS-C
- FDA Approved
- ✕No
- Prescription
- ✕No
- Strong Evidence
- ✕No
- Administration
- No approved route
- Score
- —
CJC-1295
- FDA Approved
- ✕No
- Prescription
- ✕No
- Strong Evidence
- ✕No
- Administration
- No approved route
- Score
- —
Ipamorelin
- FDA Approved
- ✕No
- Prescription
- ✕No
- Strong Evidence
- ✕No
- Administration
- No approved route
- Score
- —
Decision context
Only treatments with sufficient public evidence are included. Commercial links do not affect editorial conclusions.
MyPeptideQuest
Your evidence-first guide to peptide-based treatments. Information only. Not medical advice.